GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (ASX:RMD) » Definitions » YoY Rev. per Sh. Growth

ResMed (ASX:RMD) YoY Rev. per Sh. Growth : 5.33% (As of Sep. 2024)


View and export this data going back to 1999. Start your Free Trial

What is ResMed YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. ResMed's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 was 5.33%.

ResMed's Revenue per Share for the three months ended in Sep. 2024 was A$1.23.

ResMed YoY Rev. per Sh. Growth Historical Data

The historical data trend for ResMed's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ResMed YoY Rev. per Sh. Growth Chart

ResMed Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.24 -2.96 21.30 23.22 12.07

ResMed Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.14 13.28 9.07 10.15 5.33

ResMed YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

ResMed's YoY Rev. per Sh. Growth for the fiscal year that ended in Jun. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Jun. 2024 )
=(Revenue per Share (A: Jun. 2024 )-Revenue per Share (A: Jun. 2023 ))/ | Revenue per Share (A: Jun. 2023 ) |
=(4.782-4.267)/ | 4.267 |
=12.07 %

ResMed's YoY Rev. per Sh. Growth for the quarter that ended in Sep. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Sep. 2024 )
=(Revenue per Share (Q: Sep. 2024 )-Revenue per Share (Q: Sep. 2023 )) / | Revenue per Share (Q: Sep. 2023 )) |
=(1.225-1.163)/ | 1.163 |
=5.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ResMed YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of ResMed's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ResMed Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ResMed Inc (ASX:RMD) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
WST COO HOLX BAX ALGN AVTR ATR TFX RGEN BDX ISRG XPAR:EL TSE:7741 XSWX:ALC TSE:4543 OCSE:COLO B XSWX:STMN TSE:7733 XPAR:DIM TSE:6869
Traded in Other Exchanges
RSMDF:USA RMD:USA RMD:Mexico 0KW4:UK RME:Germany RME:Germany R1MD34:Brazil RMD:Austria
Address
9001 Spectrum Center Boulevard, San Diego, CA, USA, 92123
Website
https://www.resmed.com
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.